Drug Effective In Slowing Progressive MS, Trial Shows
By Dennis Thompson HealthDay ReporterFRIDAY, May 29, 2026 (HealthDay News) — An already-approved MS drug can significantly slow progression in people with primary progressive multiple sclerosis (PPMS), according to a new study. Patients treated with an IV infusion of ocrelizumab (Ocrevus) were less likely to have progression of their disability, researchers report in The Lancet. …